AR Health Ventures Accelerator (ARHVA) is seeking innovative proposals for therapeutic development. The program aims to accelerate scientific discoveries into practical therapies, bridging the gap between research and commercialization. Open to all UAMS employees.
Apply Now
BioVentures LLC will receive up to $2.4 million over the next four years to test prevention strategies for reducing high rates of maternal and infant
The deadline has been extended for UAMS employees to submit innovative therapeutic or drug discovery ideas to the AR Health Ventures Accelerator (ARHVA) for significant
The Arkansas Collaborative for Technological and Innovative Venture Equality (ACTIVE) is accepting applications for its 2025 cohort. This unique initiative is aimed at Arkansans who
Jamie Johnson wants to empower women by providing confidential, customized support during pregnancy, connecting them with the right resources when they need them the most.
Discover essential insights into the tech transfer process with the BioVentures Inventor’s Handbook. This resource provides UAMS researchers with valuable information on protecting intellectual property,
Medicine is changing rapidly in the face of technology and innovation. Today’s medical students must not only keep up with these changes, they should be
The AR Health Ventures Accelerator (ARHVA) invites UAMS employees to submit innovative therapeutic or drug discovery ideas for significant financial and administrative support toward commercialization.
The Health Sciences Innovation and Entrepreneurship (HSIE) Training Program has been awarded a $952,975 grant over five years to continue its pioneering work teaching postdoctoral fellows at UAMS how to commercialize their discoveries.
AR Health Ventures Accelerator proudly announces its inaugural cohort, funding innovative projects in biofilm inhibition, radiation-responsive cancer therapy, and advanced liver injury detection, marking a significant leap in medical research.
Empowering Arkansas entrepreneurs in healthcare and health tech. Receive comprehensive support and networking opportunities to accelerate your venture. Apply now to join the 2024 cohort and shape the future of healthcare entrepreneurship. Visit bioventures.tech/active to learn more and apply today!
BioVentures has announced a licensing agreement with Harmonic Discovery and UC San Francisco for the development of a new drug
Submit your proposals for the AR Health Ventures Accelerator program by September 29th. Apply now!
DISCLAIMER: Information on this website is not legal advice and should not be relied on as such. The law can change and the information contained on this site may be outdated, so you should always consult an attorney regarding your specific issues in view of the current state of the law. Please contact our team at bioventures@uams.edu if you have any questions and we can help determine a course of action.
